Literature DB >> 9841885

Differential modulation of transcriptional activity of oestrogen receptors by direct protein-protein interactions with retinoid receptors.

M R Song1, S K Lee, Y W Seo, H S Choi, J W Lee, M O Lee.   

Abstract

Control of oestradiol-responsive gene regulation by oestrogen receptors (ERs) may involve complex cross-talk with retinoic acid receptors (RARs) and retinoid X receptors (RXRs). Recently, we have shown that ERalpha directly interacts with RARalpha and RXRalpha through their ligand binding domains (LBDs). In the present work, we extend these results by showing that ERbeta binds similarly to RARalpha and RXRalpha but not to the glucocorticoid receptor, as demonstrated by the yeast two-hybrid tests and glutathione S-transferase pull-down assays. These direct interactions were also demonstrated in gel-shift assays, in which the oestrogen response element (ERE) binding by ERalpha was enhanced by the RXRalpha LBD but was abolished by the RARalpha LBD. In addition, we showed that RARalpha and RXRalpha bound the ERE as efficiently as ERalpha, suggesting that competition for DNA binding may affect the transactivation function of the ER. In transient transfection experiments, co-expression of RARalpha or RXRalpha, along with ERalpha or ERbeta, revealed differential modulation of the ERE-dependent transactivation, which was distinct from the results when each receptor alone was co-transfected. Importantly, when the LBD of RARalpha was co-expressed with ERalpha, transactivation of ERalpha on the ERE was repressed as efficiently as when wild-type RARalpha was co-expressed. Furthermore, liganded RARalpha or unliganded RXRalpha enhanced the ERalpha transactivation, suggesting the formation of transcriptionally active heterodimer complexes between the ER and retinoid receptors. Taken together, these results suggest that direct protein-protein interactions may play major roles in the determination of the biological consequences of cross-talk between ERs and RARalpha or RXRalpha.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9841885      PMCID: PMC1219924          DOI: 10.1042/bj3360711

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  49 in total

1.  Vitamin D3-thyroid hormone receptor heterodimer polarity directs ligand sensitivity of transactivation.

Authors:  M Schräder; K M Müller; S Nayeri; J P Kahlen; C Carlberg
Journal:  Nature       Date:  1994-08-04       Impact factor: 49.962

Review 2.  Insights from the study of animals lacking functional estrogen receptor.

Authors:  K S Korach
Journal:  Science       Date:  1994-12-02       Impact factor: 47.728

3.  Interplay between estrogens, progestins, retinoic acid and AP-1 on a single regulatory site in the progesterone receptor gene.

Authors:  J F Savouret; M Rauch; G Redeuilh; S Sar; A Chauchereau; K Woodruff; M G Parker; E Milgrom
Journal:  J Biol Chem       Date:  1994-11-18       Impact factor: 5.157

4.  A novel heterodimerization partner for thyroid hormone receptor. Peroxisome proliferator-activated receptor.

Authors:  F Bogazzi; L D Hudson; V M Nikodem
Journal:  J Biol Chem       Date:  1994-04-22       Impact factor: 5.157

5.  A retinoic acid response element from the rat CRBPI promoter is activated by an RAR/RXR heterodimer.

Authors:  M Husmann; B Hoffmann; D G Stump; F Chytil; M Pfahl
Journal:  Biochem Biophys Res Commun       Date:  1992-09-30       Impact factor: 3.575

Review 6.  Breast cancer chemoprevention.

Authors:  A Costa
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

7.  Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function.

Authors:  B van der Burg; B M van der Leede; L Kwakkenbos-Isbrücker; S Salverda; S W de Laat; P T van der Saag
Journal:  Mol Cell Endocrinol       Date:  1993-02       Impact factor: 4.102

8.  Antiestrogenic effects of all-trans-retinoic acid and 1,25-dihydroxyvitamin D3 in breast cancer cells occur at the estrogen response element level but through different molecular mechanisms.

Authors:  E Demirpence; P Balaguer; F Trousse; J C Nicolas; M Pons; D Gagne
Journal:  Cancer Res       Date:  1994-03-15       Impact factor: 12.701

9.  Formation of retinoid X receptor homodimers leads to repression of T3 response: hormonal cross talk by ligand-induced squelching.

Authors:  J M Lehmann; X K Zhang; G Graupner; M O Lee; T Hermann; B Hoffmann; M Pfahl
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

10.  Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene.

Authors:  D B Lubahn; J S Moyer; T S Golding; J F Couse; K S Korach; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

View more
  4 in total

Review 1.  The multi-faceted role of retinoid X receptor in bone remodeling.

Authors:  María P Menéndez-Gutiérrez; Mercedes Ricote
Journal:  Cell Mol Life Sci       Date:  2017-01-19       Impact factor: 9.261

2.  Retinoid X receptors orchestrate osteoclast differentiation and postnatal bone remodeling.

Authors:  María P Menéndez-Gutiérrez; Tamás Rőszer; Lucía Fuentes; Vanessa Núñez; Amelia Escolano; Juan Miguel Redondo; Nora De Clerck; Daniel Metzger; Annabel F Valledor; Mercedes Ricote
Journal:  J Clin Invest       Date:  2015-01-09       Impact factor: 14.808

3.  Parent-of-origin-specific binding of nuclear hormone receptor complexes in the H19-Igf2 imprinting control region.

Authors:  Piroska E Szabó; Gerd P Pfeifer; Jeffrey R Mann
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

4.  Transcriptomic Analysis Shows Decreased Cortical Expression of NR4A1, NR4A2 and RXRB in Schizophrenia and Provides Evidence for Nuclear Receptor Dysregulation.

Authors:  Susan M Corley; Shan-Yuan Tsai; Marc R Wilkins; Cynthia Shannon Weickert
Journal:  PLoS One       Date:  2016-12-16       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.